Abramson Cancer Center of the University of Pennsylvania
Last Modified: October 27, 2006
Authors: James Metz MD, Editor-in-Chief, OncoLink, Assistant Professor, Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA Maggie Hampshire RN, Managing Editor, OncoLink, University of Pennsylvania, Philadelphia, PA, USA
Saunders, Published November 23, 2006
ISBN 0702028665 | Paperback | 256 Pages | $29.95 US
Avoiding jargon, this book will answer all the questions that you have concerning risk and prevention, screening and diagnosis, through all the various treatment options available: surgery, chemotherapy, radiation therapy, hormone therapy, complementary and alternative therapies. The book will provide you with advice on living with cancer as well.
Attractively designed and clearly presented, the OncoLink Patient Guide will provide you with all the answers you are looking for safe in the knowledge that the information comes from one of the world's leading cancer Internet resources - OncoLink.
Compiled by OncoLink's cancer experts, and arranged in a question and answer style, this book is an essential purchase for all breast cancer patients, their doctors, and their caregivers.
Instant access to information
Published in collaboration with one of the world's leading Internet cancer resources - OncoLink
Expert authors and contributors from the OncoLink "Ask the Experts Team"
Arranged in a Question and Answer style
Includes a Cancer Diary with charts to help you keep track of your doctors appointments, medications, and treatments
NEW: "Talking with Your Oncology Team" section developed by physicians and nurses at the Abramson Cancer Center of the University of Pennsylvania.
Sep 9, 2013 - For patients with early breast cancer, a response-guided neoadjuvant chemotherapy approach seems beneficial, according to a study published online Sept. 3 in the Journal of Clinical Oncology.